Ghost Tree Capital’s Ambrx Biopharma Inc AMAM Stock Holding History

Ghost Tree Capital’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-475,000	Closed	-$6.76M	–	84
2023 Q4	$6.76M	Sell	475,000 -50,000	-10%	-$568K	2.21%	8
2023 Q3	$6.04M	Buy	525,000 +286,775	+120%	+$3.91M	1.99%	18
2023 Q2	$3.92M	Sell	238,225 -11,775	-5%	-$148K	1.29%	24
2023 Q1	$2.23M	Buy	+250,000	New	+$1.26M	0.66%	39

Ghost Tree Capital's AMAM Position: Q1 2024 in Review

Ghost Tree Capital sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 475,000 shares — an estimated $6.76M sold.

Ghost Tree Capital first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $6.76M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Ghost Tree Capital reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Ghost Tree Capital sold 475,000 Ambrx Biopharma Inc shares in Q1 2024, an estimated $6.76M.
Ghost Tree Capital first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
Ghost Tree Capital's Ambrx Biopharma Inc position peaked at $6.76M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Ghost Tree Capital's 13F filing for Q1 2024, filed 15 May 2024.